Bayer: Anemia trials
The registry lists 14 Anemia studies with Bayer as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 1 3Phase 2 5Phase 3 5No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Learn More About the Long-term Safety and Effectiveness of Molidustat as a Treatment for Japanese Men and Women With Renal AnemiaActive, not recruitingNCT04899661
- Maintenance Treatment of Renal Anemia in Dialysis SubjectsCompletedNCT03543657Phase 3
- A Study of Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis SubjectsCompletedNCT03418168Phase 3
- A Study of Molidustat for Correction of Renal Anemia in Dialysis SubjectsCompletedNCT03351166Phase 3
- A Study of Molidustat for Maintenance Treatment of Renal Anemia in Non-dialysis SubjectsCompletedNCT03350347Phase 3
- A Study of Molidustat for Correction of Renal Anemia in Non-dialysis SubjectsCompletedNCT03350321Phase 3
- Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934CompletedNCT02064426Phase 2
- Long-term Pre-dialysis Extension in Europe and Asia PacificCompletedNCT02055482Phase 2
- Maintenance Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease on Darbepoetin Treatment Versus BAY85-3934CompletedNCT02021409Phase 2
- 15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)CompletedNCT02021370Phase 2
- Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934CompletedNCT01975818Phase 2
- Age and Gender Effects on the Pharmacokinetics of BAY85-3934CompletedNCT01458028Phase 1
- Combined Single / Multiple Dose Escalation Study in Patients With Renal Anemia Due to CKD (Chronic Kidney Disease)CompletedNCT01332942Phase 1
- Single Dose Group Stratified Study in Renal Impaired and Healthy Aged and Gender Matched SubjectsCompletedNCT01318551Phase 1